ATE127472T1 - Zwischenverbindung für 2- alkynyladenosinherstellung, herstellung dieser zwischenverbindung, herstellung von 2- alkynyladenosin aus diesem zwischenprodukt sowie stabiles 2-alkynyladenosinderivat. - Google Patents

Zwischenverbindung für 2- alkynyladenosinherstellung, herstellung dieser zwischenverbindung, herstellung von 2- alkynyladenosin aus diesem zwischenprodukt sowie stabiles 2-alkynyladenosinderivat.

Info

Publication number
ATE127472T1
ATE127472T1 AT90909403T AT90909403T ATE127472T1 AT E127472 T1 ATE127472 T1 AT E127472T1 AT 90909403 T AT90909403 T AT 90909403T AT 90909403 T AT90909403 T AT 90909403T AT E127472 T1 ATE127472 T1 AT E127472T1
Authority
AT
Austria
Prior art keywords
alkynyladenosine
production
intermediate compound
derivative
compound
Prior art date
Application number
AT90909403T
Other languages
English (en)
Inventor
Toyofumi Heim Nishi- Yamaguchi
Takanori Miyashita
Shinji Sakata
Toichi Abiru
Akira - Minamishinkawa Matsuda
Nishi -Chome K Monbusho-Youchi
Tohru - Maruyamanishi-Mac Ueda
Kentaro Toa Eiyo Ltd Kenk Kogi
Machi
Original Assignee
Yamasa Shoyu Kk
Toa Eiyo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu Kk, Toa Eiyo Ltd filed Critical Yamasa Shoyu Kk
Application granted granted Critical
Publication of ATE127472T1 publication Critical patent/ATE127472T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Ladders (AREA)
AT90909403T 1989-06-20 1990-06-20 Zwischenverbindung für 2- alkynyladenosinherstellung, herstellung dieser zwischenverbindung, herstellung von 2- alkynyladenosin aus diesem zwischenprodukt sowie stabiles 2-alkynyladenosinderivat. ATE127472T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15751789 1989-06-20
JP472790 1990-01-13

Publications (1)

Publication Number Publication Date
ATE127472T1 true ATE127472T1 (de) 1995-09-15

Family

ID=26338545

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90909403T ATE127472T1 (de) 1989-06-20 1990-06-20 Zwischenverbindung für 2- alkynyladenosinherstellung, herstellung dieser zwischenverbindung, herstellung von 2- alkynyladenosin aus diesem zwischenprodukt sowie stabiles 2-alkynyladenosinderivat.

Country Status (8)

Country Link
US (2) US5283327A (de)
EP (1) EP0429681B1 (de)
KR (1) KR920700218A (de)
AT (1) ATE127472T1 (de)
CA (1) CA2035038C (de)
DE (1) DE69022176T2 (de)
ES (1) ES2077070T3 (de)
WO (1) WO1990015812A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189027A (en) 1990-11-30 1993-02-23 Yamasa Shoyu Kabushiki Kaisha 2-substituted adenosine derivatives and pharmaceutical compositions for circulatory diseases
JP2740362B2 (ja) * 1991-02-12 1998-04-15 ヤマサ醤油株式会社 安定な固体状2‐オクチニルアデノシンおよびその製造法
ATE263777T1 (de) * 1999-02-01 2004-04-15 Univ Virginia Zusammensetzungen zur behandlung von entzündungsreaktionen
US6214807B1 (en) * 1999-06-22 2001-04-10 Cv Therapeutics, Inc. C-pyrazole 2A A receptor agonists
US6180615B1 (en) * 1999-06-22 2001-01-30 Cv Therapeutics, Inc. Propargyl phenyl ether A2A receptor agonists
US6403567B1 (en) * 1999-06-22 2002-06-11 Cv Therapeutics, Inc. N-pyrazole A2A adenosine receptor agonists
USRE47351E1 (en) 1999-06-22 2019-04-16 Gilead Sciences, Inc. 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
CA2439222C (en) * 2000-02-23 2009-07-14 Cv Therapeutics, Inc. Identification of partial agonists of the a2a adenosine receptor
US20050020915A1 (en) * 2002-07-29 2005-01-27 Cv Therapeutics, Inc. Myocardial perfusion imaging methods and compositions
WO2004011010A1 (en) * 2002-07-29 2004-02-05 Cv Therapeutics, Inc. Myocardial perfusion imaging using a2a receptor agonists
US8470801B2 (en) 2002-07-29 2013-06-25 Gilead Sciences, Inc. Myocardial perfusion imaging methods and compositions
CA2583185A1 (en) * 2004-10-20 2006-04-27 Cv Therapeutics, Inc. Use of a2a adenosine receptor agonists
PL1989214T3 (pl) 2006-02-03 2017-07-31 Gilead Sciences, Inc. Proces otrzymywania agonisty receptora adenozynowego a2a i jego polimorfów
CA2655310A1 (en) * 2006-06-22 2008-05-29 Cv Therapeutics, Inc. Use of a2a adenosine receptor agonists in the treatment of ischemia
JP2010502649A (ja) * 2006-09-01 2010-01-28 シーブイ・セラピューティクス・インコーポレイテッド 心筋層画像化法中の患者の耐性を増加させるための方法および組成物
US20090081120A1 (en) * 2006-09-01 2009-03-26 Cv Therapeutics, Inc. Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods
JP2011502101A (ja) * 2006-09-29 2011-01-20 ギリアード・パロ・アルト・インコーポレイテッド 肺疾患の病歴を有する患者における心筋画像化法
EP2099360A2 (de) * 2007-01-03 2009-09-16 CV Therapeutics Inc. Abbildung myokardialer perfusionen
EP2344145A1 (de) * 2008-09-29 2011-07-20 Gilead Sciences, Inc. Kombinationen eines ratenkontrollierenden mittels und eines a-2-alpha-rezeptor-antagonisten zur verwendung in multidetektor-computertomographie-verfahren
US9822141B2 (en) 2012-08-01 2017-11-21 Lewis And Clark Pharmaceuticals, Inc. N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists
MX367879B (es) 2012-08-01 2019-09-10 Lewis And Clark Pharmaceuticals Inc N-alquil 2-(disustituido)alquiladenosin-5-uronamidas como agonistas a2a.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6299395A (ja) * 1985-10-25 1987-05-08 Yamasa Shoyu Co Ltd 2−アルキニルアデノシンおよび抗高血圧剤
DE68916036T2 (de) * 1988-11-15 1994-09-29 Toa Eiyo Ltd Mittel zur behandlung und prophylaxe koronarer und zerebraler ischämischer erkrankungen.

Also Published As

Publication number Publication date
KR920700218A (ko) 1992-02-19
WO1990015812A1 (en) 1990-12-27
ES2077070T3 (es) 1995-11-16
DE69022176D1 (de) 1995-10-12
US5283327A (en) 1994-02-01
EP0429681A1 (de) 1991-06-05
US5459254A (en) 1995-10-17
CA2035038C (en) 1998-12-29
DE69022176T2 (de) 1996-02-15
EP0429681A4 (en) 1992-03-11
EP0429681B1 (de) 1995-09-06
CA2035038A1 (en) 1990-12-21

Similar Documents

Publication Publication Date Title
DE69022176D1 (de) Zwischenverbindung für 2-alkynyladenosinherstellung, herstellung dieser zwischenverbindung, herstellung von 2-alkynyladenosin aus diesem zwischenprodukt sowie stabiles 2-alkynyladenosinderivat.
BG92804A (bg) 4-бензоилизоксазолови производни
FI930991A0 (fi) Polymerer som innehaoller diesterenheter
DE69714171D1 (de) Pentafluorophenylazolopyrimidine
MY111556A (en) Substituted azadioxacycloalkenes.
EP0694558A4 (de) Sphingoglycolipid und verwendung davon
DE69219221D1 (de) Vanadium Komplexe, ihre Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
EP0322182A3 (de) Azabicyclische-Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
EA199800768A1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве медикаментов
EP0775487A4 (de) Triazinderivat und medikament
CA2146877A1 (en) Sulphonyl amino carbonyl triazolinones
ZA9410181B (en) Arylacetic acid derivatives.
GR3019351T3 (en) Diaminoethylene compounds
EP0505582A4 (en) Sulfonating agent and process
ATE95054T1 (de) Anti-zahnstein zahnpasten mit erhoehter lagerfaehigkeit.
CA2021733A1 (en) Azole-substituted cycloalkanol derivative, a process to produce the same and a use of the derivative as an agricultural and horticultural fungicide
ATE167664T1 (de) Verwendung von aminen in ölzusammensetzungen
DE59404784D1 (de) Neue carbonsäureester von 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren herstellung sowie deren verwendung
IT1251202B (it) 6-amminochinoloni, sintesi ed impiego come antibatterici
ATE151090T1 (de) Herstellung von aktivierten carbamaten von polyalkylenglycol und ihre verwendung
ATE88471T1 (de) Azolylmethylcyloalkyloxirane, ihre herstellung und verwendung als pflanzenschutzmittel.
DE3265637D1 (en) Oligomer of a diisocyanate
WO1995004719A1 (de) Substituierte 4-carbamoyl-pyrrolin-2-on- und -dihydrofuran-2-on-derivate und deren verwendung als schädlingsbekämpfungsmittel
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
ATE132143T1 (de) Azolylmethylspiro-2.5-octanole und diese enthaltende fungizide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties